Drugs Made In America Acquisition Corp
DMAAU10.550USD
0.0000.00%
종가 02/03, 16:00（ET）시세는 15분 지연됩니다
0.00시가총액
--P/E TTM
자세한 내용은 Drugs Made In America Acquisition Corp 회사
Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition Corp 정보
종목 코드 DMAAU
회사 이름Drugs Made In America Acquisition Corp
상장일Jan 28, 2025
CEOStockwell (Lynn)
직원 수- -
유형Unit
회계 연도 종료- -
주소1 East Broward Boulevard
도시FT LAUDERDALE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호33301
전화19548703099
웹사이트
종목 코드 DMAAU
상장일Jan 28, 2025
CEOStockwell (Lynn)
Drugs Made In America Acquisition Corp의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Mon, Nov 17
마지막 업데이트: Mon, Nov 17
주주
주주 유형
주주
주주
비율
Drugs Made In America Acquisition LLC
17.88%
Kryger Capital Limited
1.28%
Wolverine Asset Management, LLC
0.55%
RiverNorth Capital Management LLC
0.44%
Clear Street Group Inc
0.20%
기타
79.65%
주주
주주
비율
Drugs Made In America Acquisition LLC
17.88%
Kryger Capital Limited
1.28%
Wolverine Asset Management, LLC
0.55%
RiverNorth Capital Management LLC
0.44%
Clear Street Group Inc
0.20%
기타
79.65%
주주 유형
주주
비율
Corporation
17.88%
Investment Advisor
1.52%
Hedge Fund
0.61%
Investment Advisor/Hedge Fund
0.56%
Research Firm
0.20%
기타
79.24%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
21
706.12K
14.40%
--
2025Q3
21
706.12K
14.40%
-280.00K
2025Q2
19
986.13K
14.72%
-2.41M
2025Q1
19
3.40M
0.80%
+3.21M
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Drugs Made In America Acquisition LLC
4.19M
17.88%
+4.19M
--
Feb 18, 2025
Kryger Capital Limited
300.00K
1.28%
+300.00K
--
Sep 30, 2025
Wolverine Asset Management, LLC
130.00K
0.55%
--
--
Sep 30, 2025
RiverNorth Capital Management LLC
102.37K
0.44%
-318.13K
-75.65%
Sep 30, 2025
Clear Street Group Inc
47.48K
0.2%
+47.48K
--
Sep 30, 2025
Clear Street LLC
45.92K
0.2%
+40.07K
+685.09%
Jun 30, 2025
Robinson Capital Management, LLC
30.00K
0.13%
--
--
Sep 30, 2025
Citadel Advisors LLC
11.96K
0.05%
-2.06K
-14.70%
Sep 30, 2025
UBS Financial Services, Inc.
18.39K
0.08%
--
--
Sep 30, 2025
Heights Capital Management, Inc.
--
0%
-650.00K
-100.00%
Jun 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
CrossingBridge Pre-Merger SPAC ETF
0%
SPAC and New Issue ETF
0%
RiverNorth Enhanced Pre-Merger SPAC ETF
0%
CrossingBridge Pre-Merger SPAC ETF
비율0%
SPAC and New Issue ETF
비율0%
RiverNorth Enhanced Pre-Merger SPAC ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
